Green Lifescience Co., Ltd. (KOSDAQ:114450)

Market Cap	61.31B
Revenue (ttm)	23.19B
Net Income (ttm)	-642.08M
Shares Out	19.53M
EPS (ttm)	-33.61
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,344,860
Average Volume	2,647,822
Open	3,090.00
Previous Close	3,140.00
Day's Range	3,005.00 - 3,240.00
52-Week Range	1,450.00 - 4,640.00
Beta	1.47
RSI	62.36
Earnings Date	Aug 14, 2025

About Green Lifescience

Green Lifescience Co., Ltd. engages in development, production, and sale of agrochemical raw materials and pharmaceutical intermediates in South Korea and internationally. The company offers raw materials for pharmaceuticals and pesticides; and primary intermediates to the pharmaceutical and agrochemical markets. It also develops EDP-CL, a piperacillin antibiotic intermediate; N,N-disuccinimidyl carbonate used for the synthesis of HIV treatment; Amoxapine, an antidepressant raw drug, and AM19, an antibiotic intermediate, as well as 1,1'-carbony...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2005
• Employees: 70
• Stock Exchange: KOSDAQ
• Ticker Symbol: 114450